ID | 62446 |
フルテキストURL | |
著者 |
Umeda, Yuzo
Department of Gastroenterological Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
researchmap
Mitsuhashi, Toshiharu
Center for Innovative Clinical Medicine, Okayama University Hospital
Kaken ID
researchmap
Kojima, Toru
Department of Surgery, Okayama Saiseikai General Hospital
Satoh, Daisuke
Department of Surgery, Hiroshima Citizens Hospital
researchmap
Sui, Kenta
Department of Surgery, Kochi Health Sciences Center
Endo, Yoshikatsu
Department of Surgery, Himeji Red Cross Hospital
Inagaki, Masaru
Department of Surgery, National Hospital Organization Fukuyama Medical Center
Oishi, Masahiro
Department of Surgery, Tottori Municipal Hospital
Yagi, Takahito
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
Fujiwara, Toshiyoshi
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
|
抄録 | Background: Lymph node metastasis (LNM) has been established as a critical risk factor for prognosis in intrahepatic cholangiocarcinoma (ICC). The clinical implications of lymph node dissection (LND) have been debated. This study aimed to clarify the prognostic impact of LND by multicenter retrospective analysis.
Methods: A total of 310 ICC patients who had undergone curative resection between 2000 and 2016 were retrospectively analyzed. The prognostic impact of LND was estimated under an inverse probability of treatment weighting (IPTW) approach using propensity scores. Results: LND was performed for 224 patients (72%), with LNM pathologically confirmed in 90 patients (40%). Prognosis was poorer for patients with LNM (median survival, 16.9 months) than for those without (57.2 months; P < .0001). One-, 3-, and 5-year overall survival rates (OS) were comparable among LND+ (81.6%, 48.0%, and 37.5%, respectively) and LND- groups (81.6%, 55.4%, and 44.6%, respectively). However, advanced tumor, as characterized by larger tumor, multinodular lesions, and serosal invasion, was significantly more frequent in the LND+ group than in the LND- group. After IPTW adjusting for imbalances, 1-, 3-, and 5-year OS were better in the LND+ group (83.5%, 52.2%, and 42.8%, respectively) than in the LND- group (71.9%, 32.4%, and 23.4%, respectively; P = .046). LND thus showed significant prognostic impact (hazard ratio = 0.58, 95%CI = |0.39|-|0.84|, P = .005), especially in hilar ICC. However, peripheral ICC displayed no therapeutic benefit from LND. Conclusions: LND could have a significant role to play in improving oncologic outcomes. Therapeutic LND should be implemented on the basis of tumor location and tumor advancement. |
キーワード | intrahepatic cholangiocarcinoma
lymph node excision
multicenter study
propensity score
retrospective studies
|
備考 | This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
|
発行日 | 2021-9-16
|
出版物タイトル |
Journal of Hepato-Biliary-Pancreatic Sciences
|
出版者 | Wiley
|
開始ページ | 1
|
終了ページ | 13
|
ISSN | 1868-6974
|
NCID | AA12507209
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2021 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery.
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.1002/jhbp.1038
|
ライセンス | http://creativecommons.org/licenses/by/4.0/
|
Citation | Umeda Y, Mitsuhashi T, Kojima T, Satoh D, Sui K, Endo Y, et al. Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis. J Hepatobiliary Pancreat Sci. 2021;00:1–13. https://doi.org/10.1002/jhbp.1038
|
助成機関名 |
日本学術振興会
|
助成番号 | 19K09217
|